INS | Insulin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/48/1693_B_2_7_rna_selected_60x60.jpg) | Tissue enriched |
PIK3R1 | Phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | Cancer-related genes Disease related genes Plasma proteins RAS pathway related proteins
| | ![](/images/1216/if_selected_60x60.jpg) | | ![](/images/4268/19233_B_8_6_rna_selected_60x60.jpg) | Expressed in all |
PTPN1 | Protein tyrosine phosphatase, non-receptor type 1 | Enzymes Predicted membrane proteins
| | | | ![](/images/15217/36055_B_3_4_rna_selected_60x60.jpg) | Expressed in all |
SORBS1 | Sorbin and SH3 domain containing 1 | | | | ![](/images_static/rna_center.gif) | ![](/images/27559/58594_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
IGF2R | Insulin-like growth factor 2 receptor | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | ![](/images/11332/ihc_cell_selected_60x60.jpg) | ![](/images/11332/29187_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
PRKCZ | Protein kinase C, zeta | Enzymes Plasma proteins
| | ![](/images/21851/if_selected_60x60.jpg) | | ![](/images/21851/49689_B_9_3_rna_selected_60x60.jpg) | Mixed |
PTPN11 | Protein tyrosine phosphatase, non-receptor type 11 | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets RAS pathway related proteins
| | ![](/images/5377/if_selected_60x60.jpg) | ![](/images/5377/ihc_cell_selected_60x60.jpg) | ![](/images/5377/18256_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
PDX1 | Pancreatic and duodenal homeobox 1 | Disease related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/25873/54798_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
SLC2A4 | Solute carrier family 2 (facilitated glucose transporter), member 4 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/16544/ihc_cell_selected_60x60.jpg) | ![](/images/16544/35881_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/32904/78602_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
GIP | Gastric inhibitory polypeptide | Plasma proteins Predicted secreted proteins
| | ![](/images/21612/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/21612/140668_B_8_3_rna_selected_60x60.jpg) | Group enriched |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46972/146495_B_7_7_rna_selected_60x60.jpg) | Group enriched |
INSL3 | Insulin-like 3 (Leydig cell) | Disease related genes Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/28615/59748_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
AKT2 | V-akt murine thymoma viral oncogene homolog 2 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | ![](/images_static/na_center.gif) | ![](/images/4204/ihc_cell_selected_60x60.jpg) | ![](/images/4204/11545_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
BAIAP2 | BAI1-associated protein 2 | Plasma proteins
| | | | ![](/images/27421/57220_B_2_7_rna_selected_60x60.jpg) | Expressed in all |
GCG | Glucagon | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/40/ihc_cell_selected_60x60.jpg) | ![](/images/40/343_B_7_3_rna_selected_60x60.jpg) | Tissue enriched |
GHRL | Ghrelin/obestatin prepropeptide | Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/14246/143314_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
INSL5 | Insulin-like 5 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/30100/140637_B_1_8_rna_selected_60x60.jpg) | Group enriched |
INSL6 | Insulin-like 6 | Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/21364/ihc_cell_selected_60x60.jpg) | ![](/images/21364/50592_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
KCNA5 | Potassium voltage-gated channel, shaker-related subfamily, member 5 | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/21516/109609_B_7_2_rna_selected_60x60.jpg) | Group enriched |
NEUROD1 | Neuronal differentiation 1 | Disease related genes Transcription factors
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3278/10188_B_8_5_rna_selected_60x60.jpg) | Group enriched |
PDE3B | Phosphodiesterase 3B, cGMP-inhibited | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/9497/31482_A_1_6_rna_selected_60x60.jpg) | Tissue enhanced |
PDPK1 | 3-phosphoinositide dependent protein kinase-1 | Enzymes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/4272/11742_B_7_3_rna_selected_60x60.jpg) | Expressed in all |
PIK3CA | Phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | ![](/images/9985/if_selected_60x60.jpg) | ![](/images/9985/ihc_cell_selected_60x60.jpg) | ![](/images/9985/24712_B_7_7_rna_selected_60x60.jpg) | Expressed in all |
PRKCD | Protein kinase C, delta | Cancer-related genes Disease related genes Enzymes Potential drug targets
| | ![](/images/10469/if_selected_60x60.jpg) | | ![](/images/1890/6250_A_9_6_rna_selected_60x60.jpg) | Mixed |
PRKCE | Protein kinase C, epsilon | Cancer-related genes Cytoskeleton related proteins Enzymes
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/1948/5310_A_6_1_rna_selected_60x60.jpg) | Expressed in all |
AKT1 | V-akt murine thymoma viral oncogene homolog 1 | Cancer-related genes Disease related genes Enzymes Potential drug targets RAS pathway related proteins
| | | | ![](/images/2891/7679_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
HADH | Hydroxyacyl-CoA dehydrogenase | Disease related genes Enzymes Mitochondrial proteins Potential drug targets
| | | ![](/images/39588/ihc_cell_selected_60x60.jpg) | ![](/images/39588/85592_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
IGF2BP1 | Insulin-like growth factor 2 mRNA binding protein 1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/62273/149779_A_1_2_rna_selected_60x60.jpg) | Group enriched |
MYO5A | Myosin VA (heavy chain 12, myoxin) | Disease related genes Plasma proteins
| | ![](/images/1356/if_selected_60x60.jpg) | ![](/images/1356/ihc_cell_selected_60x60.jpg) | ![](/images/1356/4099_B_7_3_rna_selected_60x60.jpg) | Expressed in all |
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | Mitochondrial proteins RAS pathway related proteins
| | | ![](/images/5374/ihc_cell_selected_60x60.jpg) | ![](/images/5374/27881_B_7_3_rna_selected_60x60.jpg) | Expressed in all |
APPL1 | Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1 | | | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/11138/29028_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
BAD | BCL2-associated agonist of cell death | Cancer-related genes Mitochondrial proteins RAS pathway related proteins
| | | ![](/images/28185/ihc_cell_selected_60x60.jpg) | ![](/images/28185/61307_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
CACNA1C | Calcium channel, voltage-dependent, L type, alpha 1C subunit | Disease related genes FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/39796/84042_B_8_3_rna_selected_60x60.jpg) | Tissue enhanced |
DOK1 | Docking protein 1, 62kDa (downstream of tyrosine kinase 1) | Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/4224/19030_B_9_2_rna_selected_60x60.jpg) | Expressed in all |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/19427/42464_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Cancer-related genes
| | | | ![](/images/5039/15090_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
GAL | Galanin/GMAP prepropeptide | Plasma proteins Predicted secreted proteins
| | ![](/images/49864/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/49864/127576_B_8_4_rna_selected_60x60.jpg) | Tissue enhanced |
HNF1A | HNF1 homeobox A | Cancer-related genes Disease related genes Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/35231/124722_B_2_6_rna_selected_60x60.jpg) | Tissue enhanced |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/40948/92377_B_7_8_rna_selected_60x60.jpg) | Group enriched |
IGFBP7 | Insulin-like growth factor binding protein 7 | Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images/20668/if_selected_60x60.jpg) | ![](/images/20668/ihc_cell_selected_60x60.jpg) | ![](/images/20668/45942_B_7_8_rna_selected_60x60.jpg) | Expressed in all |
KCNB1 | Potassium voltage-gated channel, Shab-related subfamily, member 1 | FDA approved drug targets Predicted membrane proteins Transporters Voltage-gated ion channels
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/42434/134323_B_1_7_rna_selected_60x60.jpg) | Tissue enhanced |
OGT | O-linked N-acetylglucosamine (GlcNAc) transferase | Disease related genes Enzymes Potential drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/34099/67976_A_3_2_rna_selected_60x60.jpg) | Expressed in all |
PCK1 | Phosphoenolpyruvate carboxykinase 1 (soluble) | Citric acid cycle related proteins Disease related genes Enzymes Potential drug targets
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6277/18455_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
PID1 | Phosphotyrosine interaction domain containing 1 | | | | ![](/images_static/rna_center.gif) | ![](/images/36103/71519_B_9_8_rna_selected_60x60.jpg) | Mixed |
PRKAA1 | Protein kinase, AMP-activated, alpha 1 catalytic subunit | Enzymes FDA approved drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/5050/17832_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
PRKCA | Protein kinase C, alpha | Cancer-related genes Enzymes Plasma proteins RAS pathway related proteins
| | | | ![](/images/6563/18017_B_9_3_rna_selected_60x60.jpg) | Expressed in all |
PSMD9 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 9 | Plasma proteins
| | ![](/images/40512/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/44220/115310_B_7_3_rna_selected_60x60.jpg) | Expressed in all |
PTPN2 | Protein tyrosine phosphatase, non-receptor type 2 | Enzymes Predicted membrane proteins
| | ![](/images_static/na_center.gif) | ![](/images/15004/ihc_cell_selected_60x60.jpg) | ![](/images/15004/128831_B_3_1_rna_selected_60x60.jpg) | Expressed in all |
RBP4 | Retinol binding protein 4, plasma | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1641/6042_B_1_3_rna_selected_60x60.jpg) | Tissue enriched |